SARS-CoV-2 Antibody Point-of-Care Testing in Dialysis and Kidney Transplant Patients With COVID-19

RATIONALE & OBJECTIVE: A number of serologic tests for immunoglobulin G (IgG) against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are now commercially available, including multiple lateral flow immunoassays (LFIAs), which have the advantage of being inexpensive and easy to use,...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Kidney Med
Autors principals: Prendecki, Maria, Clarke, Candice, McKinnon, Tom, Lightstone, Liz, Pickering, Matthew C., Thomas, David C., McAdoo, Stephen P., Willicombe, Michelle
Format: Artigo
Idioma:Inglês
Publicat: Elsevier 2020
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7834810/
https://ncbi.nlm.nih.gov/pubmed/33521621
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.xkme.2020.09.010
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars